DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $879,000 | +9.9% | 10,277 | 0.0% | 0.46% | +5.7% |
| Q4 2016 | $800,000 | -0.9% | 10,277 | -0.2% | 0.44% | -3.7% |
| Q3 2016 | $807,000 | -18.1% | 10,297 | +5.5% | 0.46% | -17.7% |
| Q2 2016 | $985,000 | +10.4% | 9,756 | +3.7% | 0.55% | +7.2% |
| Q1 2016 | $892,000 | +7.5% | 9,406 | +5.2% | 0.52% | +7.9% |
| Q4 2015 | $830,000 | +9.2% | 8,941 | +0.3% | 0.48% | -0.2% |
| Q3 2015 | $760,000 | +5.4% | 8,916 | +5.8% | 0.48% | +5.7% |
| Q2 2015 | $721,000 | +4.3% | 8,425 | +3.6% | 0.45% | +3.9% |
| Q1 2015 | $691,000 | +15.2% | 8,135 | +16.2% | 0.44% | +9.8% |
| Q4 2014 | $600,000 | +30.7% | 7,000 | +15.9% | 0.40% | +24.5% |
| Q3 2014 | $459,000 | +10.1% | 6,042 | +14.0% | 0.32% | -6.2% |
| Q2 2014 | $417,000 | +5.8% | 5,300 | +1.0% | 0.34% | +5.3% |
| Q1 2014 | $394,000 | +0.8% | 5,250 | +3.8% | 0.32% | +0.3% |
| Q4 2013 | $391,000 | – | 5,060 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |